...
【24h】

Serum adiponectin levels in adult growth hormone deficiency and acromegaly.

机译:血清脂联素水平在成人中生长激素缺乏和肢端肥大症。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Atherosclerosis and insulin resistance are common complications of adult growth hormone deficiency (GHD) and acromegaly. Circulating adiponectin, an adipocyte-derived protein, has both anti-atherogenic and insulin-sensitising effects. In this study, we measured serum adiponectin levels in patients with either adult GHD or acromegaly to clarify the impact of GH secretory states on the regulation of serum adiponectin levels. Serum adiponectin level was measured by radioimmunoassay in 32 patients with adult GHD, 49 patients with acromegaly and 25 normal subjects. The relationships between adiponectin and insulin sensitivity index assessed as quantitative insulin sensitivity check index (QUICKI), BMI, and serum GH and IGF-I levels were then investigated. The values of QUICKI were significantly lower in patients with acromegaly or adult GHD compared to normal subjects (0.33+/-0.03, P<0.01, 0.35+/-0.04, P<0.05 and 0.36+/-0.01, respectively). While patients with adult GHD had significantly lower serum adiponectin levels than patients with acromegaly (6.5+/-3.9, 9.2+/-5.0, P<0.01) these levels were not significantly different from those found in normal subjects (7.8+/-4.3 mug/ml). There was an inverse correlation between serum adiponectin levels and BMI in both patient groups (GHD r=-0.39, P<0.05; Acromegaly r=-0.35, P<0.05). However, serum adiponectin levels correlated positively with QUICKI (R(s)=0.37, P<0.05) only in patients with adult GHD. In patients with acromegaly, the levels of circulating adiponectin showed an inverse correlation with serum IGF-I levels (R(s)=-0.34, P<0.05), but not with basal GH levels. These results demonstrate that adiponectin levels are significantly lower in patients with adult GHD than in patients with acromegaly. Adiponectin levels are similar in patients with GHD and healthy controls, whereas in patients with acromegaly, insulin resistance appears to be not closely related to adiponectin levels compared with BMI. The different relationship between adiponectin and QUICKI observed in the adult GHD and acromegaly groups presumably reflects differences in the mechanisms of insulin resistance under states of GH deficiency or excess.
机译:动脉粥样硬化和胰岛素抵抗是成人生长激素缺乏症(GHD)和肢端肥大症的常见并发症。循环脂联素是一种来自脂肪细胞的蛋白质,具有抗动脉粥样硬化作用和胰岛素敏感性作用。在这项研究中,我们测量了成年GHD或肢端肥大症患者的血清脂联素水平,以阐明GH分泌状态对血清脂联素水平调节的影响。通过放射免疫法测定了32名成人GHD患者,49名肢端肥大患者和25名正常人的血清脂联素水平。然后研究了脂联素与胰岛素敏感性指数之间的关系,该指数被评估为定量胰岛素敏感性检查指数(QUICKI),BMI,血清GH和IGF-I水平。与正常人相比,肢端肥大症或成人GHD患者的QUICKI值显着较低(分别为0.33 +/- 0.03,P <0.01、0.35 +/- 0.04,P <0.05和0.36 +/- 0.01)。尽管成人GHD患者的血清脂联素水平显着低于肢端肥大症患者(6.5 +/- 3.9,9.2 +/- 5.0,P <0.01),但这些水平与正常受试者的血清脂联素水平没有明显差异(7.8 +/- 4.3)杯/毫升)。两组患者血清脂联素水平与BMI呈负相关(GHD r = -0.39,P <0.05; Acromegaly r = -0.35,P <0.05)。然而,仅在成年GHD患者中,血清脂联素水平与QUICKI正相关(R(s)= 0.37,P <0.05)。在肢端肥大症患者中,循环脂联素水平与血清​​IGF-I水平呈负相关(R(s)=-0.34,P <0.05),而与基础GH水平无负相关。这些结果表明,成年GHD患者的脂联素水平显着低于肢端肥大症患者。 GHD患者和健康对照者的脂联素水平相似,而肢端肥大症患者的胰岛素抵抗与BMI相比似乎与脂联素水平没有密切关系。在成人GHD和肢端肥大人群中观察到的脂联素和QUICKI之间的不同关系可能反映了在GH缺乏或过量状态下胰岛素抵抗机制的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号